Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Oxymorphone

    Client Email Product

    Oxymorphone

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    3
    US DMFs Filed

    US DMFs Filed

    1
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    2
    API REF. PRICE (USD / KG)
    2,433

    API Market Place

    0

    INTERMEDIATES
    1
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    2
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS
    201
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    25
    REF STANDARD

    EDQM

    0

    USP

    4

    JP

    0

    Other Listed Suppliers

    4
    SERVICES

    0

    Full View ScreenFull Screen View
    Impax Inks $145M Deal With Direct Purchasers In Opana MDL
    Impax Inks $145M Deal With Direct Purchasers In Opana MDL

    https://www.law360.com/lifesciences/articles/1513329?utm_source=feedly&utm_medium=rss&utm_campaign=section

    Lauraann Wood LAW360
    20 Jul 2022
    Share Share
    Families impacted by the opioid epidemic closely watching J&J trial
    Families impacted by the opioid epidemic closely watching J&J trial

    https://www.cbsnews.com/news/johnson-and-johnson-families-impacted-by-opioid-epidemic-closely-watching-trial-today-2019-05-28/

    CBSNEWS
    28 May 2019
    Share Share
    FDA declines to approve Mallinckrodt's abuse-deterrent opioid painkiller
    FDA declines to approve Mallinckrodt's abuse-deterrent opioid painkiller

    https://www.reuters.com/article/us-mallinckrodt-fda/fda-declines-to-approve-mallinckrodts-abuse-deterrent-opioid-painkiller-idUSKBN1OB1BO?feedType=RSS&feedName=healthNews

    Tamara Mathias REUTERS
    13 Dec 2018
    Share Share
    FDA to Replace Analgesic Drug Development Guidance With New Documents
    FDA to Replace Analgesic Drug Development Guidance With New Documents

    https://www.raps.org/news-and-articles/news-articles/2018/8/fda-to-replace-analgesic-drug-development-guidance?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2030%20August

    Michael Mezher RAPS
    30 Aug 2018
    Share Share
    FDA declines to approve Pain Therapeutics' opioid drug, shares plunge
    FDA declines to approve Pain Therapeutics' opioid drug, shares plunge

    https://www.reuters.com/article/us-pain-therapeutic-fda/fda-declines-to-approve-pain-therapeutics-abuse-deterrent-opioid-drug-idUSKBN1KR195

    Manas Mishra REUTERS
    07 Aug 2018
    Share Share
    Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis
    Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis

    https://www.fiercepharma.com/legal/mallinckrodt-probed-over-oxymorphone-generics-growing-opioid-crisis

    E. Sagonowsky FIERCE PHARMA
    01 Mar 2018
    Share Share
    Ascent Pharm’s Generics Oxymorphone Hydrochloride Receives Approval In US
    Ascent Pharm’s Generics Oxymorphone Hydrochloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210175

    FDA
    07 Feb 2018
    Share Share
    U.S. subpoenas Endo for information on opioid painkillers
    U.S. subpoenas Endo for information on opioid painkillers

    https://www.reuters.com/article/us-endo-intl-subpeona/u-s-subpoenas-endo-for-information-on-opioid-painkillers-idUSKBN1F01T3

    Nate Raymond REUTERS
    11 Jan 2018
    Share Share
    Impax Announces Settlement of Contract Litigation on Opana® ER Oxymorphone HCL
    Impax Announces Settlement of Contract Litigation on Opana® ER Oxymorphone HCL

    http://www.prnewswire.com/news-releases/impax-announces-settlement-of-contract-litigation-on-opana-er-oxymorphone-hydrochloride-cii-extended-release-tablets-300500192.html

    PR NEWSWIRE
    07 Aug 2017
    Share Share
    News of Note—GlaxoSmithKline’s R&D fix; Leo-HitGen deal; Stanford I-O pact
    News of Note—GlaxoSmithKline’s R&D fix; Leo-HitGen deal; Stanford I-O pact

    http://www.fiercebiotech.com/biotech/news-note-gsk-s-r-d-fix-leo-hitgen-deal-stanford-i-o-pact?utm_source=internal&utm_medium=rss

    Nick P. Taylor FIERCE BIOTECH
    07 Aug 2017
    Share Share
    Spoiler alert: IBD superheroes prevail as Takeda wraps its Marvel Comics project
    Spoiler alert: IBD superheroes prevail as Takeda wraps its Marvel Comics project

    http://www.fiercepharma.com/marketing/takeda-debuts-final-chapters-ibd-superheroes-comic-book-wraps-first-marvel-co

    Beth S.Bulik FIERCE PHARMA
    07 Aug 2017
    Share Share
    Report Calls on FDA to Adopt New Standard for Reviewing Opioids
    Report Calls on FDA to Adopt New Standard for Reviewing Opioids

    http://www.raps.org/Regulatory-Focus/News/2017/07/14/28087/Report-Calls-on-FDA-to-Adopt-New-Standard-for-Reviewing-Opioids/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails

    Michael Mezher RAPS
    15 Jul 2017
    Share Share
    Endo Pulls Opioid From US Market at FDA's Request
    Endo Pulls Opioid From US Market at FDA's Request

    http://raps.org/Regulatory-Focus/News/2017/07/06/28045/Endo-Pulls-Opioid-From-US-Market-at-FDAs-Request/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails

    Zachary Brennan RAPS
    07 Jul 2017
    Share Share
    FDA Asks Drug Company to Pull its Opioid Opana Because of Abuse
    FDA Asks Drug Company to Pull its Opioid Opana Because of Abuse

    http://www.nbcnews.com/storyline/americas-heroin-epidemic/fda-asks-drug-company-pull-its-opioid-opana-because-abuse-n770121

    MAGGIE FOX NBC NEWS
    08 Jun 2017
    Share Share
    Endo's (ENDP) Opana ER's Risk Benefit Evaluated by FDA
    Endo's (ENDP) Opana ER's Risk Benefit Evaluated by FDA

    http://www.nasdaq.com/article/endos-endp-opana-ers-risk-benefit-evaluated-by-fda-cm761979

    NASDAQ
    16 Mar 2017
    Share Share
    FDA Panel To Re-Examine Opana ER
    FDA Panel To Re-Examine Opana ER

    http://seekingalpha.com/article/4054181-fda-panel-re-examine-opana-er

    SEEKING ALPHA
    11 Mar 2017
    Share Share
    Is Kratom a Deadly Drug or a Life-Saving Medicine?
    Is Kratom a Deadly Drug or a Life-Saving Medicine?

    https://www.bloomberg.com/news/features/2016-12-12/is-kratom-a-deadly-drug-or-a-life-saving-medicine

    Bryan Gruley BLOOMBERG
    20 Dec 2016
    Share Share
    Endo withdraws bid to add 'abuse deterrent' to Opana's label
    Endo withdraws bid to add 'abuse deterrent' to Opana's label

    http://www.fiercepharma.com/pharma/endo-withdraws-bid-to-add-abuse-deterrent-to-opana-s-label

    Carly Helfand FIERCE PHARMA
    12 Aug 2016
    Share Share
    Aurobindo Pharma gets US Food and Drug Administration nod for two drugs
    Aurobindo Pharma gets US Food and Drug Administration nod for two drugs

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-us-food-and-drug-administration-nod-for-two-drugs/articleshow/52006823.cms

    ECONOMIC TIMES
    26 Apr 2016
    Share Share
    KemPharm plans to develop prodrug of oxymorphone
    KemPharm plans to develop prodrug of oxymorphone

    http://www.biospectrumasia.com/biospectrum/news/223065/kempharm-plans-develop-prodrug-oxymorphone

    BioSpectrum Bureau BIOSPECTRUM ASIA
    04 Jan 2016
    Share Share
    Endo Announces U.S. District Court Ruling Upholding OPANA® ER Intellectual Property
    Endo Announces U.S. District Court Ruling Upholding OPANA® ER Intellectual Property

    http://www.prnewswire.com/news-releases/endo-announces-us-district-court-ruling-upholding-opana-er-intellectual-property-300128849.html

    PR NEWS WIRE
    14 Aug 2015
    Share Share
    Endo's Opana ER (Oxymorphone Hcl) Receives Supplemental Approval in US For Pain
    Endo's Opana ER (Oxymorphone Hcl) Receives Supplemental Approval in US For Pain

    https://www.pharmacompass.com/pdf/news/endo.pdf

    FDA
    24 Jun 2015
    Share Share
    Abandoned Painkiller Makes a Comeback
    Abandoned Painkiller Makes a Comeback

    http://www.medpagetoday.com/Psychiatry/Addictions/51448

     John Fauber MEDPAGE TODAY
    10 May 2015
    Share Share
    Collegium swings for a $75M IPO for its abuse-proof painkiller
    Collegium swings for a $75M IPO for its abuse-proof painkiller

    http://www.fiercebiotech.com/story/collegium-swings-75m-ipo-its-abuse-proof-painkiller/2015-05-01

     Damian Garde FIERCE BIOTECH
    01 May 2015
    Share Share
    Sun's Generic Oxymorphone Hcl Approved in USA For Moderate to Severe Pain
    Sun's Generic Oxymorphone Hcl Approved in USA For Moderate to Severe Pain

    https://www.pharmacompass.com/pdf/news/suns-generic-oxymorphone-hcl-approved-in-usa-for-moderate-to-severe-pain-1443365933.pdf

    Press Release FDA
    30 Apr 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search